Spike N. Loy
Director/Board Member at MOONLAKE IMMUNOTHERAPEUTICS
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jorge da Silva | M | 47 |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 2 years |
| Kristian Reich | M | 58 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 2 years |
| Matthias Bodenstedt | M | 36 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 2 years |
| Ramnik Xavier | M | 62 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 2 years |
| Simon Sturge | M | 65 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 3 years |
| Kara Lassen | M | 45 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 2 years |
| Andrew Phillips | M | 53 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 2 years |
| Catherine Moukheibir | F | 64 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 2 years |
| Julie Ryan | F | 38 | 3 years | |
| Arnout Ploos van Amstel | M | 60 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 3 years |
| Michael Forer | M | 58 |
GH Research Ireland Ltd.
 GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GH Research Ireland Ltd. is an Irish clinical-stage biopharmaceutical company that develops innovative therapies for the treatment of mental illnesses. The company is based in Dublin, Ireland and is a subsidiary of GH Research Plc. | 4 years |
| Oliver Daltrop | M | 47 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | 3 years |
| Aaron Cameron | M | 39 | 3 years | |
| Nuala Brennan | F | 55 | 3 years | |
| Nicolas Mosimann | M | - | - | |
| Joao Neves | M | - | - | |
| Robert L. Joss | M | 82 |
Stanford University
| 25 years |
| Dermot Hanley | M | - | 3 years | |
| Patrícia Isabel Sousa Caldinha | F | - | 2 years | |
| Randall Livingston | M | 70 |
Stanford University
| 23 years |
| James R. Swartz | M | - |
Stanford University
| 26 years |
| Daniel D. Gretler | M | - |
Stanford University
| 23 years |
| Thomas Krummel | M | 72 |
Stanford University
| 26 years |
| Bernd Girod | M | - |
Stanford University
| 25 years |
| Florian Schönharting | M | 55 |
GH Research Ireland Ltd.
GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GH Research Ireland Ltd. is an Irish clinical-stage biopharmaceutical company that develops innovative therapies for the treatment of mental illnesses. The company is based in Dublin, Ireland and is a subsidiary of GH Research Plc. | - |
| Benjamin van Roy | M | - |
Stanford University
| 26 years |
| Duncan Moore | M | 65 | 3 years | |
| Dragos Budinschi | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Styrmir Sigurjonsson | M | 50 |
Stanford University
| 7 years |
| Balaji S. Srinivasan | M | - |
Stanford University
| 9 years |
| Gregory Malcom Tusher | M | - |
Stanford University
| 13 years |
| Krishna Gorti | M | - |
Stanford University
| 5 years |
| Karen Martell | F | - |
Stanford University
| 4 years |
| Lyndsay Erickson | F | - |
Stanford University
| 5 years |
| Yvonne Gavrilis | F | - |
Stanford University
| 5 years |
| Daniel J. Estes | M | 43 |
Stanford University
| 4 years |
| Philip Satre | M | 74 |
Stanford University
| 4 years |
| Jason Min | M | - |
Stanford University
| 6 years |
| Amit Garg | M | - |
Stanford University
| 5 years |
| Stephen D. Klein | M | - |
Stanford University
| 5 years |
| Alex Gurevich | M | - |
Stanford University
| 5 years |
| Ben S. Abadi | M | - |
Stanford University
| 4 years |
| Siddharth Joshi | M | - |
Stanford University
| 6 years |
| Prajna Murdaya | M | 48 |
Stanford University
| 6 years |
| Steve Abraham | M | - |
Stanford University
| 5 years |
| Y. Dan Rubinstein | M | - |
Stanford University
| 6 years |
| Alex Popa | M | - |
Stanford University
| 4 years |
| William Chan | M | - |
Stanford University
| 3 years |
| Zheng Su | F | - |
Stanford University
| 4 years |
| Erin Yang | F | - |
Stanford University
| 5 years |
| Matt Patterson | M | - |
Stanford University
| 4 years |
| Michael E Webber | M | - |
Stanford University
| 6 years |
| Tenbite Ermias | M | - |
Stanford University
| 8 years |
| Jeremy Ginsberg | M | - |
Stanford University
| 5 years |
| Elizabeth Loboa | M | 57 |
Stanford University
| 7 years |
| Pieter Abbeel | M | - |
Stanford University
| 8 years |
| Todd Jackson | M | - |
Stanford University
| 4 years |
| Dustin Espersen | M | - |
Stanford University
| 5 years |
| Eric Bahn | M | - |
Stanford University
| 5 years |
| Justin Wilson | M | 42 |
Stanford University
| 5 years |
| Jonathan Hsu | M | - |
Stanford University
| 5 years |
| Christopher E Olin | M | - |
Stanford University
| 7 years |
| Darren Bechtel | M | - |
Stanford University
| 10 years |
| Elizabeth Xie | M | - |
Stanford University
| 6 years |
| Erica Malin | F | - |
Stanford University
| 4 years |
| Gina Sanchez | F | - |
Stanford University
| 5 years |
| Timothy Stonehocker | M | 43 |
Stanford University
| 4 years |
| Alex Scherbakovsky | M | - |
Stanford University
| 4 years |
| Ziang Tony Ngo | M | 45 |
Stanford University
| 4 years |
| Matthew Pauker | M | - |
Stanford University
| 4 years |
| Manu Kumar | M | - |
Stanford University
| 5 years |
| Aaron Partridge | M | - |
Stanford University
| 5 years |
| Hung Hoang | M | - |
Stanford University
| 3 years |
| Scott A. Baker | M | - |
Stanford University
| 4 years |
| Jenny P. Chen | F | - |
Stanford University
| 3 years |
| Ravi Belani | M | - |
Stanford University
| 4 years |
| John D. Knoll | M | 52 |
Stanford University
| 11 years |
| Jennifer W. Kheng | F | - |
Stanford University
| 4 years |
| Steve Herrod | M | - |
Stanford University
| 6 years |
| Brett Garrett | M | - |
Stanford University
| 5 years |
| Marissa Mayer | F | 48 |
Stanford University
| 6 years |
| Trevor Loy | M | - |
Stanford University
| 10 years |
| Andrew Gustin | M | - |
Stanford University
| 9 years |
| Bret Taylor | M | 43 |
Stanford University
| 5 years |
| Laudan N. Fariborz | F | - |
Stanford University
| 7 years |
| Christopher James Wilson | M | - |
Stanford University
| 3 years |
| Elizabeth Weil | F | - |
Stanford University
| 6 years |
| David Miller | M | - |
Stanford University
| 3 years |
| Gee-Liek Yeo | M | - |
Stanford University
| 6 years |
| Puneet Agarwal | M | - |
Stanford University
| 5 years |
| Ash Upadhyaya | M | 45 |
Stanford University
| 2 years |
| David Topham | M | - |
Stanford University
| 4 years |
| Lou Fernandes | M | - |
Stanford University
| 2 years |
| Mike Rothenberg | M | - |
Stanford University
| 5 years |
| Matthew E. Spiegelman | M | - |
Stanford University
| 5 years |
| Benjamin Perdue Olding | M | - |
Stanford University
| 6 years |
| Brian Morfitt | M | - |
Stanford University
| 5 years |
| Martin Ekström | M | - |
Stanford University
| 4 years |
| Tom Fountain | M | 47 |
Stanford University
| 7 years |
| Darren Minton | M | 41 |
Stanford University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 79 | 79.00% |
| Switzerland | 10 | 10.00% |
| Ireland | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Spike N. Loy
- Personal Network
